Tamara S Hannon Selected Research

Tamara S Hannon Research Topics

Disease

17	Insulin Resistance 01/2021 - 08/2005
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2014
7	Prediabetic State (Prediabetes) 01/2021 - 04/2012
6	Glucose Intolerance 08/2021 - 01/2018
6	Overweight 12/2019 - 10/2006
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 05/2018
4	Obesity 01/2019 - 08/2005
2	Obstructive Sleep Apnea 01/2021 - 01/2018
2	Weight Loss (Weight Reduction) 01/2021 - 11/2011
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2018 - 04/2011
2	Crohn Disease (Crohn's Disease) 01/2011 - 03/2007
2	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 06/2008 - 08/2007
2	Neoplasms (Cancer) 10/2004 - 11/2003
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Hyperglycemia 01/2020
1	Sleepiness 12/2019
1	Disorders of Excessive Somnolence (Hypersomnia) 12/2019
1	Jet Lag Syndrome 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hyperaldosteronism (Conn Syndrome) 06/2014
1	Hypertension (High Blood Pressure) 06/2014
1	Body Weight (Weight, Body) 11/2011
1	Pediatric Obesity 11/2011
1	Cushing Syndrome 06/2008
1	Fibrous Dysplasia of Bone 08/2007
1	Precocious Puberty 08/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2006
1	Dyslipidemias (Dyslipidemia) 10/2006
1	Ovarian Neoplasms (Ovarian Cancer) 10/2004
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 08/2004
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 08/2004
1	Endocrine System Diseases (Endocrine Diseases) 05/2003
1	Hyperthyroidism 05/2003
1	Granulosa Cell Tumor 01/2002

Drug/Important Bio-Agent (IBA)

20	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2006
10	Insulin (Novolin)FDA Link 12/2020 - 08/2005
4	Proteins (Proteins, Gene)FDA Link 01/2011 - 11/2003
3	C-PeptideIBA 01/2021 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 04/2012
2	Glucagon (Glukagon)FDA Link 01/2021 - 01/2021
2	Arginine (L-Arginine)FDA Link 01/2021 - 01/2020
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 09/2015 - 12/2014
2	DNA (Deoxyribonucleic Acid)IBA 08/2007 - 01/2002
1	Insulin Glargine (Lantus)FDA Link 01/2021
1	ProinsulinIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	IncretinsIBA 01/2018
1	oxidized low density lipoproteinIBA 12/2014
1	Lipoproteins (Lipoprotein)IBA 12/2014
1	Acarbose FDA LinkGeneric 11/2014
1	AldosteroneIBA 06/2014
1	FludrocortisoneIBA 06/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2012
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2012
1	CalciumIBA 11/2011
1	Parathyroid Hormone (Parathormone)IBA 11/2011
1	Calcium Carbonate (Limestone)FDA Link 11/2011
1	Human Growth Hormone (Saizen)FDA LinkGeneric 01/2011
1	GonadotropinsIBA 08/2007
1	Growth Hormone (Somatotropin)IBA 12/2006
1	Triglycerides (Triacylglycerol)IBA 10/2006
1	HDL LipoproteinsIBA 10/2006
1	AdiponectinIBA 10/2006
1	RNA (Ribonucleic Acid)IBA 10/2004
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2004
1	Proteasome InhibitorsIBA 10/2004
1	Dual Specificity Phosphatase 1IBA 10/2004
1	SaltsIBA 08/2004
1	delta proteinIBA 11/2003
1	Gs GTP-Binding Protein alpha Subunits (G(s)alpha)IBA 05/2003
1	FSH Receptors (FSH Receptor)IBA 01/2002

Therapy/Procedure

3	Glycemic Control 01/2020 - 05/2018
1	Aftercare (After-Treatment) 08/2021
1	Therapeutics 01/2019
1	Adrenalectomy 06/2008
1	Enteral Nutrition (Feeding, Tube) 03/2007
1	Thyroidectomy 05/2003